Jeffrey B. Kindler - Dec 28, 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Dec 28, 2023
Transactions value $
-$136,327
Form type
4
Date filed
12/29/2023, 07:19 PM
Previous filing
Jun 14, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Sale -$136K -96.7K -28.86% $1.41 238K Dec 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 28, 2023, Jeffrey Kindler, a Director of the Issuer, entered into a Stock Purchase Agreement with Parkview 2020 Limited Partnership ("Parkview 2020"), an affiliate of Randal J. Kirk, also a Director of the Issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the Issuer at a price per share of $1.41, which purchase price was determined based upon the closing price of the Issuer's common stock on December 28, 2023.